1,748 results · 20ms · Sources: EU EUDAMED, US FDA

Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)

FDA classification
FDA Class 3 ·Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)

Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component)

FDA classification
FDA Class 3 ·Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component)

Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic, Cemented

FDA classification
FDA Class 3 ·Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic, Cemented

Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)

FDA classification
FDA Class 3 ·Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)

Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

FDA classification
FDA Class 3 ·Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit

FDA classification
FDA Class 3 ·Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit

Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented

FDA classification
FDA Class 3 ·Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented

Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

FDA classification
FDA Class 3 ·Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement